KVUE Stock Overview
Operates as a consumer health company worldwide. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 1/6 |
Financial Health | 2/6 |
Dividends | 1/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Narratives bring a range of perspectives from our community.
Kenvue Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$21.20 |
52 Week High | US$24.46 |
52 Week Low | US$17.67 |
Beta | 0 |
1 Month Change | -7.18% |
3 Month Change | -3.59% |
1 Year Change | -0.70% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -21.19% |
Recent News & Updates
Kenvue Inc.'s (NYSE:KVUE) Intrinsic Value Is Potentially 70% Above Its Share Price
Jan 04Kenvue (NYSE:KVUE) Seems To Use Debt Quite Sensibly
Dec 08Kenvue: Lots Of Potential, But Short-Term Upside May Be Tapped Out (Rating Downgrade)
Nov 27Recent updates
Kenvue Inc.'s (NYSE:KVUE) Intrinsic Value Is Potentially 70% Above Its Share Price
Jan 04Kenvue (NYSE:KVUE) Seems To Use Debt Quite Sensibly
Dec 08Kenvue: Lots Of Potential, But Short-Term Upside May Be Tapped Out (Rating Downgrade)
Nov 27Kenvue: Unpacking Activist's Case And Earnings Preview
Oct 29Kenvue (NYSE:KVUE) Has Affirmed Its Dividend Of $0.205
Oct 22Investors Met With Slowing Returns on Capital At Kenvue (NYSE:KVUE)
Oct 07Kenvue: Turning Cautious On The Stock While Remaining Optimistic On The Business
Oct 02Kenvue (NYSE:KVUE) Has A Pretty Healthy Balance Sheet
Sep 08Kenvue: Promising Steps Toward Long-Term Success
Aug 11Kenvue Is A Premier Consumer Company, But I Am Waiting For A Lower Price Before I Buy
Aug 02Is There An Opportunity With Kenvue Inc.'s (NYSE:KVUE) 36% Undervaluation?
Jul 15Kenvue: A 4% Yield Worth Going Long
Jun 12Kenvue's (NYSE:KVUE) Soft Earnings Don't Show The Whole Picture
May 21Kenvue Q1 Earnings Preview: A Potentially Troubling Trend
May 03Kenvue: Fairly Valued Spinout
Apr 17Is Kenvue Inc. (NYSE:KVUE) Trading At A 31% Discount?
Apr 08Kenvue: This Dividend Newcomer Is Worth A Look
Feb 13Kenvue: What To Expect From Its First Full-Year Report As A Standalone Company
Feb 05Kenvue: Portfolio Filled Of Market Leaders
Dec 20Kenvue: Dude, Where's My Dividend Growth?
Nov 26Kenvue: Only A Watchlist Stock For Now
Nov 19Kenvue: Consumer Health Giant's Journey From IPO To Legal Challenges And Beyond
Oct 19Kenvue: Interesting Times
Sep 18Kenvue: Charting A Healthy Future In Consumer Health
Sep 06Kenvue Split-Off: Still Undecided? 3 (And A Half) Aspects To Consider
Aug 16Kenvue: A Buffett-Style Investment At A Reasonable Price
Jul 11Johnson & Johnson Spinoff Kenvue Is Worth Owning - But Maybe Not Yet
Jun 13Shareholder Returns
KVUE | US Personal Products | US Market | |
---|---|---|---|
7D | -1.5% | -2.2% | -0.2% |
1Y | -0.7% | -24.7% | 25.6% |
Return vs Industry: KVUE exceeded the US Personal Products industry which returned -24.7% over the past year.
Return vs Market: KVUE underperformed the US Market which returned 25.6% over the past year.
Price Volatility
KVUE volatility | |
---|---|
KVUE Average Weekly Movement | 3.1% |
Personal Products Industry Average Movement | 8.1% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 18.3% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: KVUE has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: KVUE's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2022 | 22,000 | Thibaut Mongon | www.kenvue.com |
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Kenvue Inc. Fundamentals Summary
KVUE fundamental statistics | |
---|---|
Market cap | US$40.65b |
Earnings (TTM) | US$1.06b |
Revenue (TTM) | US$15.46b |
38.2x
P/E Ratio2.6x
P/S RatioIs KVUE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KVUE income statement (TTM) | |
---|---|
Revenue | US$15.46b |
Cost of Revenue | US$6.51b |
Gross Profit | US$8.95b |
Other Expenses | US$7.89b |
Earnings | US$1.06b |
Last Reported Earnings
Sep 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.55 |
Gross Margin | 57.90% |
Net Profit Margin | 6.88% |
Debt/Equity Ratio | 80.7% |
How did KVUE perform over the long term?
See historical performance and comparisonDividends
3.9%
Current Dividend Yield145%
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/05 01:43 |
End of Day Share Price | 2025/01/03 00:00 |
Earnings | 2024/09/29 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kenvue Inc. is covered by 20 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Ishan Majumdar | Baptista Research |
Lauren Lieberman | Barclays |
Navann Ty Dietschi | BNP Paribas Exane |